Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-03

Clinical Trial Update: Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence [Phase 1, Phase 2]

View source ↗

Summary

Results from a combined Phase 1/2 safety and efficacy study of a new treatment for urinary incontinence have been posted by Beech Tree Labs, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • New Urinary Incontinence Treatment

Snippet

Sponsor: Beech Tree Labs, Inc. | Conditions: Urinary Incontinence | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-05-03